BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20132367)

  • 1. The human papillomavirus in women over 40: implications for practice and recommendations for screening.
    Montgomery K; Bloch JR
    J Am Acad Nurse Pract; 2010 Feb; 22(2):92-100. PubMed ID: 20132367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do cervical cancer screening patient information leaflets meet the HPV information needs of women?
    Hall B; Howard K; McCaffery K
    Patient Educ Couns; 2008 Jul; 72(1):78-87. PubMed ID: 18372144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do women in the U.S. know about human papillomavirus and cervical cancer?
    Tiro JA; Meissner HI; Kobrin S; Chollette V
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):288-94. PubMed ID: 17267388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.
    Vanslyke JG; Baum J; Plaza V; Otero M; Wheeler C; Helitzer DL
    Qual Health Res; 2008 May; 18(5):584-96. PubMed ID: 18337618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.
    Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Lo SS; Lee PW; Ngan HY
    BJOG; 2009 Mar; 116(4):501-10. PubMed ID: 19250361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC; Beal MW
    J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of female nursing students' knowledge, health beliefs, perceptions of risk, and risk behaviors regarding human papillomavirus and cervical cancer.
    Denny-Smith T; Bairan A; Page MC
    J Am Acad Nurse Pract; 2006 Feb; 18(2):62-9. PubMed ID: 16460412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus and cervical cancer knowledge, health beliefs, and preventative practices in older women.
    Montgomery K; Bloch JR; Bhattacharya A; Montgomery O
    J Obstet Gynecol Neonatal Nurs; 2010; 39(3):238-49. PubMed ID: 20576067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education.
    Baay MF; Verhoeven V; Peremans L; Avonts D; Vermorken JB
    Patient Educ Couns; 2006 Aug; 62(2):277-81. PubMed ID: 16533588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking cervical cancer to the human papillomavirus: findings from a qualitative study with Mexican women.
    Garcia SG; Becker D; Tatum C; Aldrich T; Fernández-C A
    Health Care Women Int; 2007 Feb; 28(2):192-205. PubMed ID: 17364980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
    Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
    Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.